UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Vicus Capital

Vicus Capital lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 12.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 541 shares of the healthcare conglomerate’s stock after purchasing an additional 58 shares during the quarter. Vicus Capital’s holdings in UnitedHealth Group were worth $274,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. AMF Tjanstepension AB increased its stake in UnitedHealth Group by 88.0% during the third quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock worth $151,374,000 after acquiring an additional 121,180 shares during the last quarter. Hudson Value Partners LLC grew its stake in shares of UnitedHealth Group by 8.3% in the third quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock valued at $625,000 after buying an additional 82 shares in the last quarter. Wealth Group Ltd. grew its stake in shares of UnitedHealth Group by 4.0% in the third quarter. Wealth Group Ltd. now owns 1,777 shares of the healthcare conglomerate’s stock valued at $1,039,000 after buying an additional 68 shares in the last quarter. Creative Planning grew its stake in shares of UnitedHealth Group by 11.0% in the third quarter. Creative Planning now owns 212,295 shares of the healthcare conglomerate’s stock valued at $123,025,000 after buying an additional 21,114 shares in the last quarter. Finally, Good Life Advisors LLC grew its stake in shares of UnitedHealth Group by 50.6% in the third quarter. Good Life Advisors LLC now owns 1,545 shares of the healthcare conglomerate’s stock valued at $903,000 after buying an additional 519 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction dated Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE UNH opened at $523.48 on Friday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The business’s 50 day moving average is $523.63 and its two-hundred day moving average is $563.48. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The stock has a market capitalization of $481.75 billion, a price-to-earnings ratio of 33.77, a PEG ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the previous year, the firm posted $5.83 EPS. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the company. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. TD Cowen lifted their price target on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a report on Friday, January 10th. Stephens lifted their price target on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Finally, Piper Sandler reduced their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.